MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)

Sections

I. Name and Type

II. Natural derivative

III. Chemical profile

Name:

MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)

Type:

Synthetic cannabinoid

AKA:

MDMB-CHMICA, MMB-CHMINACA

II. Natural Derivative

Synthetic substance, no natural derivative

III. Chemical Profile (IUPAC name)

InChI=1S/C23H32N2O3/c1-23(2,3)20(22(27)28-4)24-21(26)18-15-25(14-16-10-6-5-7-11-16)19-13-9-8-12-17(18)19/h8-9,12-13,15-16,20H,5-7,10-11,14H2,1-4H3,(H,24,26)/t20-/m1/s1

IV. History

MDMB-CHMICA and MMB-CHMINACA, synthetic cannabinoids developed in the 2010s, are part of research into cannabinoid receptors. They are known for their psychoactive effects and have been associated with recreational use and regulatory controls.

V. Legal Information

MDMB-CHMINACA and MMB-CHMINACA, synthetic cannabinoids, are often regulated under analog laws due to their psychoactive effects. Their status varies by jurisdiction.

US Federal Schedule - I

Key US Federal Policies:

VI. Physical Effects

MDMB-CHMICA and MMB-CHMINACA are synthetic cannabinoids with intense psychoactive effects. As an upper, they induce euphoria and altered perception. Short-term effects include increased heart rate and potential anxiety, while long-term use may lead to psychological issues. Overdose risks involve severe agitation and cardiovascular problems. Safe use involves cautious dosing, and recent research highlights their potency and risks.

VII. Psychological Effects

MDMB-CHMINACA, a synthetic cannabinoid, affects cannabinoid receptors, causing altered mood and perception. Immediate effects include euphoria and relaxation, while long-term use may lead to cognitive impairments and psychological issues. Effects last several hours, with risks of severe mental health disturbances and dependence with prolonged use.

VIII. Culture

MDMB-CHMINACA is a synthetic cannabinoid, classifying it as a downer. Short-term use induces relaxation and altered perceptions, while long-term use can lead to dependence and cognitive impairment. Overdose risks include severe sedation, cognitive effects, and potential psychosis. Safe dosages are not well-established, with minimal use recommended. Recent research highlights its high potency and associated cognitive risks. Physical effects include drowsiness, altered perceptions, and potential for impaired motor skills.